International Review of Ophthalmology ›› 2021, Vol. 45 ›› Issue (2): 81-88.doi: 10.3760/cma.j.issn.1673-5803.2021.02.001

    Next Articles

Treatment of non-arteritic anterior ischemic optic neuropathy

Wang Ling, Yang Hui   

  1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China
  • Received:2020-05-14 Online:2021-04-22 Published:2021-04-28
  • Contact: Yang Hui, Email: yanghui9@hotmail.com
  • Supported by:
    National Natural Science Foundation of China (81870656)　

PDF (PC)

3060

Abstract: Nonarteritic anterior ischemic optic neuropathy (NAION) is one of optic neuropathy with complex pathogenesis, which involves systemic vascular risk factors and regional anatomical factors. Control of systemic risk factors is the key to treatment. At present, the three major treatment attempts include improving circulation (such as intraocular pressure intervention, extracorporeal counterpulsation and surgery), reducing optic disc edema (such as systemic or local corticosteroid, local intravitreal injection of anti neovascularization drugs), and neurotrophic agents (such as stem cells therapy).(Int Rev Ophthalmol, 2021, 45: 81-88)


Key words: nonarteritic anterior ischemic optic neuropathy, optic neuropathy/treatment, optic neuropathy/prevention